Negri, Luca
Cilia, Sabina
Falautano, Monica
Grobberio, Monica
Niccolai, Claudia
Pattini, Marianna
Pietrolongo, Erika
Quartuccio, Maria Esmeralda
Viterbo, Rosa Gemma
Allegri, Beatrice
Amato, Maria Pia
Benin, Miriam
De Luca, Giovanna
Gasperini, Claudio
Minacapelli, Eleonora
Patti, Francesco
Trojano, Maria
Bassi, Marta http://orcid.org/0000-0003-0886-3989
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (2014/R/4)
Università degli Studi di Milano
Article History
Received: 17 May 2021
Accepted: 25 July 2021
First Online: 7 August 2021
Change Date: 2 November 2021
Change Type: Update
Change Details: Funding note has been added.
Declarations
:
: The study protocol was approved by local ethical committees of all the participating centers.
: Participants received thorough oral and written information on the study and signed the written consent form prior to participation.
: Luca Negri, Sabina Cilia, Monica Falautano, Monica Grobberio, Claudia Niccolai, Marianna Pattini, Erika Pietrolongo, Maria Esmeralda Quartuccio, Beatrice Allegri, Miriam Benin, Giovanna De Luca, Eleonora Minacapelli, and Marta Bassi declare no conflicts of interest except for Grant Nr. 2014/R/4.Rosa Gemma Viterbo received speaker honoraria from Biogen, Merck-Serono, and Sanofi.Maria Pia Amato received compensation for consulting services and/or speaking activities from Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Roche, Pharmaceutical Industries, and Fondazione Italiana Sclerosi Multipla.Claudio Gasperini received personal compensation for speaking activities and serving on advisory boards by Almirall, Bayer, Biogen, Merck, Mylan, Novartis, Roche, Sanofi, and Teva.Francesco Patti received personal compensation for speaking activities and serving on advisor board by Almirall, Bayer, Biogen, Celgene, Merck, Myalin, Novartis, Roche, Sanofi, and Teva. He also received research grants by Biogen, Merck, Reload onlus.Maria Trojano has served on scientific advisory boards for Biogen, Merck Serono, Novartis, and Roche; received speaker honoraria from Biogen, Merck-Serono, Novartis, Sanofi, and Roche; and received research grants from Biogen, Merck-Serono, Novartis, and Roche.